Skip to main content
SpringerLink
Log in

Prognostic Implication of Primary Treatment of Uterine Low-grade Endometrial Stromal Sarcoma: a Case Series

  • Case Report
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Safety Communications. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. Silver Spring, MD: U.S. Food and Drug Administration, April 18, 2014

  2. Cucinella G, Granese R, Calagna G, Somigliana E, Perino A (2011) Parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril 96:e90–e96

    Article  Google Scholar 

  3. Bogani G, Cliby WA, Aletti GD (2015) Impact of morcellation on survival outcomes of patients with unexpected uterine leiomyosarcoma: a systematic review and meta-analysis. Gynecol Oncol 137(1):167–172. https://doi.org/10.1016/j.ygyno.2014.11.011

    Article  PubMed  Google Scholar 

  4. (2015) Hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women. J Minim Invasive Gynecol 22(4):696–697. https://doi.org/10.1016/j.jmig.2015.01.015

  5. Tan-Kim J, Hartzell KA, Reinsch CS et al (2015, 212) Uterine sarcomas and parasitic myomas after laparoscopic hysterectomy with power morcellation. Am J Obstet Gynecol (5):594.e1–594.e10. https://doi.org/10.1016/j.ajog.2014.12.002

  6. Parker W, Pritts E, Olive D Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical

  7. Vargas MV, Cohen SL, Fuchs WN et al (2015) Open power morcellation versus contained power morcellation within an insufflated isolation bag: comparison of perioperative outcomes. J Minim Invasive Gynecol 22:433–438

    Article  Google Scholar 

  8. U.S. Food and Drug Administration. News release: FDA allows marketing of first-of-kind tissue containment system for use with certain laparoscopic power morcellators in select patients. April 7, 2016

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, Regional Cancer Centre, Thiruvananthapuram, India

    S. Suchetha & P. Rema

  2. Department of Surgical Oncology, Regional Cancer Centre, Thiruvananthapuram, India

    J. Sivaranjith & Shaji Thomas

Authors
  1. S. Suchetha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Sivaranjith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Rema
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shaji Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Suchetha.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suchetha, S., Sivaranjith, J., Rema, P. et al. Prognostic Implication of Primary Treatment of Uterine Low-grade Endometrial Stromal Sarcoma: a Case Series. Indian J Surg Oncol 11 (Suppl 1), 131–133 (2020). https://doi.org/10.1007/s13193-020-01100-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-020-01100-y

Search

Navigation